Sandeep Chidambar Kulkarni - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Sandeep Chidambar Kulkarni has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying.
Profile
Sandeep Chidambar Kulkarni is Director and Chairman at Amanat Acquisition Corp. (AMAN). SEC records also connect Kulkarni to Zura Bio Ltd (ZURA) and Tourmaline Bio, Inc. (TRML). Kulkarni has reported 6 insider filings with the SEC since 2024. The most recent filing was in May 2026.
| Role | Director and Chairman, Director, 10% Owner |
|---|---|
| Notability | 50/100 |
Board memberships
- Amanat Acquisition Corp.
- Zura Bio Ltd
- Tourmaline Bio, Inc.
Reported roles
- Director and Chairman
Trading Pattern
InsiderAlpha's records for Sandeep Chidambar Kulkarni go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Sandeep Chidambar Kulkarni has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director and Chairman, Director, 10% Owner at Amanat Acquisition Corp. (AMAN) - 1 filing, 2026
- Chief Executive Officer at Zura Bio Ltd (ZURA) - 2 filings, 2026
- CEO at Tourmaline Bio, Inc. (TRML) - 2 filings, 2025
- Insider at Zura Bio Ltd (ZURA) - 1 filing, 2024
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | AMAN | Amanat Acquisition Corp. | P - Open-market purchase | 300.0K | - | |
| 2025-10-28 | TRML | Tourmaline Bio, Inc. | J - Other acquisition / disposition | 7.0K | - | |
| 2025-10-28 | TRML | Tourmaline Bio, Inc. | D - Derivative transaction | 30.4K | - | |
| 2025-10-28 | TRML | Tourmaline Bio, Inc. | J - Other acquisition / disposition | 724.7K | - | |
| 2025-10-24 | TRML | Tourmaline Bio, Inc. | M - Option exercise | 25.3K | $7.90 | $200K |
Companies - Last 90 Days
- Amanat Acquisition Corp. (AMAN) - 1 filing, last 2026-05-22
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Sandeep Chidambar Kulkarni has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Amanat Sponsor Holdings LLC - of AMAN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Nicholas S. Schorsch
- Trygve Seglem
- Lawrence B. Seidman
- Thomas J. Shaw
- Silver Point Capital L.P.
- SilverBay Capital Management LLC
- Michael Simanovsky
- Bob R. Simpson
Frequently Asked Questions
Who is Sandeep Chidambar Kulkarni?
Sandeep Chidambar Kulkarni is Director and Chairman at Amanat Acquisition Corp. (AMAN). SEC records also connect Kulkarni to Zura Bio Ltd (ZURA) and Tourmaline Bio, Inc. (TRML). Kulkarni has reported 6 insider filings with the SEC since 2024. The most recent filing was in May 2026.…
How many SEC Form 4 filings has Sandeep Chidambar Kulkarni submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sandeep Chidambar Kulkarni been buying or selling stock?
Recorded transactions: 1 open-market purchase and 0 open-market sales across all tracked filings.
Where can I see all of Sandeep Chidambar Kulkarni's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Sandeep Chidambar Kulkarni profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.